Key result
Inhibiting Ca2+-calmodulin and energy metabolism reduces platelet PAF binding by ~65%.
Why the study?
Are platelet-activating factor (PAF) receptors on human platelets subject to intracellular control mechanisms?
Are platelet-activating factor (PAF) receptors on human platelets subject to intracellular control mechanisms?
PAF receptors on human platelets undergo active intracellular regulation linked to cellular energy levels and Ca2+-calmodulin-dependent processes, revealing a key mechanistic insight into platelet biology.
No immediate change to antiplatelet practice; leaves open energy- and calmodulin-dependent PAF receptor regulation for mechanistic study.
Human platelets possess about 300 receptors for platelet-activating factor (PAF) per cell with a Kd of about 0.2 nM. In the present study we investigated whether these receptors are subject to intracellular control mechanisms. Preincubation with the protein kinase C inhibitor staurosporine had no effect, and also agents that increase cyclic AMP failed to change the binding of [3H]PAF. The Ca(2+)-calmodulin inhibitors W-7 and sphingosine decreased PAF binding by 50-80%. Inhibition of energy metabolism induced a fall in adenylate energy charge [AEC = ([ATP] + 1/2[ADP])([ATP + ADP + AMP])] and an almost parallel decrease in specific [3H]PAF binding without changing the Kd. Restoration of the AEC restored the [3H]PAF binding. Abrupt arrest of energy metabolism during binding of [3H]PAF left the binding unchanged until the metabolic ATP level had decreased by about 90%. These data indicate that PAF receptors on human platelets are under close intracellular control, possibly via a Ca(2+)-calmodulin-dependent phosphorylation/dephosphorylation process.
No takes yet. Share an insight, caveat, or question.
Burgers et al. (1993) studied Healthy. Intracellular signaling and metabolic modulators (W-7, sphingosine, 2-deoxy-D-glucose, antimycin A) vs. Untreated control platelets was evaluated on Specific binding of [3H]PAF. Inhibition of Ca2+-calmodulin and energy metabolism decreased specific PAF binding on human platelets by 50-80%, indicating that PAF receptors are under close intracellular control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: